Website profile

Marketscreener

Stock market quotes, news, charts, financials, technical analysis and stocks, indexes, commodities, forex trading strategies.

  • 7,977articles · 30d
  • 2+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 77%with images
  • 139avg words
articles per day
Categories
  • Economy, Business & Finance 7,293
  • Finance & Business 6,142
  • News 4,351
  • Business & Industrial 1,465
  • Finance 1,033
  • Industrial 679
  • Transportation 345
  • Politics 220

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

MarketScreener
marketscreener.com > news > iss-sets-new-financial-targets-aims-for-a-margin-of-up-to-6-0-percent-in-2028-ce785bdcd88afe23

ISS sets new financial targets, aims for a margin of up to 6.0 percent in 2028

6+ hour, 21+ min ago   (124+ words) marketscreener.com Danish services group ISS is presenting new financial targets for the 2026-2028 period ahead of Monday's capital markets day.The company is targeting average annual organic growth of more than 5 percent over the period and an operating margin of…...

MarketScreener
marketscreener.com > news > bnp-paribas-raises-price-target-for-iss-to-258-danish-kroner-246-reiterates-neutral-bn-ce785bdcd88af02d

BNP Paribas raises price target for ISS to 258 Danish kroner (246), reiterates neutral - BN

6+ hour, 28+ min ago   (272+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. BNP Paribas raises price target for ISS to 258 Danish…...

Google News
marketscreener.com > news > astrazeneca-s-phase-3-trial-of-combination-treatment-for-breast-cancer-fails-to-meet-primary-endpoin-ce785bdcd88bf227

AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint

7+ hour, 18+ min ago   (48+ words) Published on 09/13/2026 at 11:24 pm EDT AstraZeneca: Share price weakness of late, should be capitalised on September 04, 2026 at 08:13 am EDT AstraZeneca Is Said to Have Explored Bristol Myers Merger Heading for a major healthcare merger between AstraZeneca and Bristol-Myers Squibb?...

MarketScreener
marketscreener.com > news > certain-warrants-of-swarmer-inc-are-subject-to-a-lock-up-agreement-ending-on-14-sep-2026-ce785bdcd889f525

Certain Warrants of Swarmer, Inc are subject to a Lock-Up Agreement Ending on 14-SEP-2026.

10+ hour, 5+ min ago   (87+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Certain Warrants of Swarmer, Inc are subject to a…...

MarketScreener
marketscreener.com > news > lion-copper-and-gold-corp-will-change-its-name-to-lion-copper-corp-ce785bdcd889f624

Lion Copper and Gold Corp. will Change its Name to Lion Copper Corp

10+ hour, 6+ min ago   (41+ words) marketscreener.com Published on 09/13/2026 at 08:36 pm EDT Effective September 14, 2026, Lion Copper and Gold Corp. will change its name to Lion Copper Corp....

MarketScreener
marketscreener.com > news > china-s-ligent-technologies-seeks-up-to-723-million-in-hong-kong-ipo-ce785bdcd981f127

China's Ligent Technologies seeks $723 million in Hong Kong IPO

12+ hour, 31+ min ago   (159+ words) Published on 09/13/2026 at 06:11 pm EDT - Modified on 09/13/2026 at 06:46 pm EDT Sept 14 (Reuters) - China's Ligent Technologies is looking to raise HK$5.67 billion ($723.02 million) through an initial public offering in Hong Kong, according to a filing with the exchange on Monday. The…...

MarketScreener
marketscreener.com > news > chemicals-group-evonik-to-close-bitterfeld-site-ce785bdcd98cfe24

Chemicals group Evonik to close Bitterfeld site

22+ hour, 17+ min ago   (181+ words) marketscreener.com ESSEN/BITTERFELD (dpa-AFX) - Chemicals group Evonik will close its Bitterfeld site next spring The company said the move reflects persistently challenging market conditions Plant utilization has for some time been insufficient to ensure economically viable operations Various options,…...

MarketScreener
marketscreener.com > news > 133-900-preferred-stock-of-bridgebio-pharma-inc-are-subject-to-a-lock-up-agreement-ending-on-13-se-ce785bdcd98bf621

133,900 Preferred Stock of BridgeBio Pharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026.

1+ day, 10+ hour ago   (144+ words) marketscreener.com 133,900 Preferred Stock of BridgeBio Pharma, Inc are subject to a Lock-Up Agreement Ending on 13-SEP-2026 These Preferred Stock will be under lockup for 31 days starting from 13-AUG-2026 to 13-SEP-2026.Details:The selling stockholder has agreed with the underwriters,…...

MarketScreener
marketscreener.com > news > abu-dhabi-government-eyes-collaboration-with-germany-s-bayer-ce785bdcd98dff20

Abu Dhabi Government Eyes Collaboration With Germany's Bayer

1+ day, 1+ hour ago   (42+ words) Published on 09/13/2026 at 05:42 am EDT Donald Trump prepares new agreements to reduce drug prices August 31, 2026 at 02:13 pm EDT Bayer: Q2 surpassed expectations; now focus on deleveraging and operational delivery Can Bayer Still Recover?...

MarketScreener
marketscreener.com > news > certain-units-of-ui-boustead-real-estate-investment-trust-are-subject-to-a-lock-up-agreement-ending-ce785bdcd98bf624

Certain Units of UI Boustead Real Estate Investment Trust are subject to a Lock-Up Agreement Ending on 13-SEP-2026.

1+ day, 10+ hour ago   (66+ words) marketscreener.com Certain Units of UI Boustead Real Estate Investment Trust are subject to a Lock-Up Agreement Ending on 13-SEP-2026 These Units will be under lockup for 186 days starting from 11-MAR-2026 to 13-SEP-2026.Details:UIB Singapore Investments 1 Pte (UIBSGI1), UIB Holdings…...